Craft
  • Home
  •  / Pear Therapeutics
Pear Therapeutics

Pear Therapeutics

Total Funding

$227.8 M

Pear Therapeutics Summary

Company summary

Overview
Pear Therapeutics is a company developing drug-software combination therapies to help people with mental and behavioral health issues. The company combines pharmaceutical therapy with software technology, such as digital applications and games. Pear has products at different stages of the development pipeline, including marketed products, across therapeutic areas such as mental health disorders, severe insomnia, and multiple sclerosis.
Type
Private
Founded
2013
HQ
Boston, MA, US | view all locations
Website
https://peartherapeutics.com/
Cybersecurity rating
Sectors

Key people

  • Corey McCann

    Corey McCann, President & CEO, Director

  • Chris Guiffre
  • Yuri Maricich

    Yuri Maricich, Chief Medical Officer, Head of Development

  • Erin Brenner

    Erin Brenner, Chief Product Development Officer

Operating MetricsView all

Academic Partners

5

Aug, 2019

Commercial Partners

2

Aug, 2019

Development Partners

6

Aug, 2019

LocationsView all

2 locations detected

  • Boston, MA HQ

    United States

    200 State St

  • San Francisco, CA

    United States

    201 Mission Street

Footer menu